Navigation Links
University of Florida Startup Launches Million-dollar Indiegogo Campaign to Eliminate Painful Needle Injections for Insulin
Date:8/4/2014

Gainesville, FL (PRWEB) August 04, 2014

A University of Florida biotech spinoff has launched an Indiegogo campaign to raise $1,000,000 to advance development of their groundbreaking needle-free, temperature stable insulin patches. These patches are expected to replace billions of painful needle injections every year and improve the lives patients around the world with Type I and Type II diabetes as well as those who are pre-diabetic.

Founded by former faculty at UF and Harvard Medical School, Stephen Hsu, MD-PhD, Prometheon Pharma seeks to improve not only individual patients’ lives, but also significantly reduce the burden of healthcare costs on nations and society.

“Diabetes and prediabetes is a global epidemic. The treatment method has not made any significant improvements since 1922 with patients needing at least one needle prick per day to as many as five or six,” said Dr. Hsu. “They have to carry these needles everywhere they go and if they so much as miss one dose, the outcome can be very dangerous.”

Prometheon Pharma hopes that the Indiegogo funding (http://www.igg.me/at/nopricks) will support costly studies that will allow the company to apply for FDA approval to begin clinical trials on humans.

“We are ready to rapidly move through all the required testing to get into Phase I clinical trials. We chose Indiegogo because we also want to raise public awareness of the personal impact of diabetes alongside the breakthrough technology of the patch. Advocating for patients is a very important mission for us,” said Hsu.

The Indiegogo campaign will run until September 8th and offers perks for funders supporting this sustainable healthcare initiative.

Prometheon’s goal is to have the patch available to patients by 2018, which is approximately half the time it typically takes to get a completely new drug to market, since insulin is already FDA-approved with a long track record of safety and efficacy. Prometheon Pharma’s patch will continuously and consistently deliver insulin for up to 7 days, and can be replaced at any time to suit user lifestyle and convenience. Insulin delivery can also be immediately stopped by removing the patch, an advantage over oral, inhaled, or injected insulin delivery.

While diabetes is the first application for Prometheon, the patch platform technology would later be applied to vaccines, chemotherapy, and many other injectable drugs. Its simplicity, low manufacturing cost and significantly reduced reliance on cold storage also mean that rural and impoverished populations will equally benefit from this disruptive technology.

“I can’t begin to tell you how much better my life would be, how much more freedom I would feel, and how much easier it would be to stick to my insulin regimen if I didn’t have to inject myself anymore. Any reduction would be amazing. This product will change the world, and the lives of countless millions living with diabetes,” said Bret McCall, a UF student who has been living with Type 1 diabetes since 2005.

Prometheon Pharma is a startup housed in the globally #1 ranked Sid Martin Biotech Incubator at the University of Florida.

About Prometheon Pharma LLC:

Headquartered in the University of Florida’s Sid Martin Biotechnology Incubator, Prometheon Pharma is dedicated to advancing global health equity by developing the first needle-free transdermal, low-refrigeration patches for insulin and other large peptide and protein drugs. Prometheon Pharma is poised to bring needle-free technology for passive delivery of large molecule drugs across the skin to the market as convenient, simple, and affordable health care products, which includes an insulin patch for persons suffering from diabetes. Prometheon is also pursuing a new class of anti-obesity drugs and other pharmaceutical innovations to increase worldwide access to needed drug therapies.

Press inquiries: E-mail: contact(at)prometheonpharma(dot)com
http://www.NoPricks.com/

Read the full story at http://www.prweb.com/releases/2014/08/prweb12069199.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Frontier Nursing University Receives $700,000 in Scholarships for Advanced Practice Nursing and Midwifery Students
2. Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary
3. MyMobileUniversity and Fortech International Form Strategic Alliance That Will Enhance the Global Health and Medical Channel on Its Website
4. MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors
5. National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville
6. Vedic living in a modern world: International conference at Maharishi University
7. New network unites university health care research
8. Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine
9. “Extreme Weight Loss”: Cassie’s journey begins at the University of Colorado Anschutz Health and Wellness Center
10. Pri-Med and the University of South Carolina School of Medicine Launch National Ultrasound Education Initiative for Primary Care Clinicians
11. University of Utah researcher Robert Marc receives Paul Kayser International Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... , ... April 21, 2017 , ... Providing broad access ... in opposition, but there is a better way to address this problem. , That ... of Pharmacy, Public Policy and Economics at the University of Southern California, who served ...
(Date:4/21/2017)... ... April 21, 2017 , ... Chicago plastic surgeon, ... of osteoma. An osteoma is a benign bony lump located on the forehead usually ... can cause difficulties with sight and pain. Dr. Shah has discovered an approach that ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... Allegheny County that offers services to communities throughout the greater Pittsburgh metropolitan region, ... charity drive to provide adaptive bicycles for differently-abled children. , Variety the Children’s ...
(Date:4/21/2017)... ... , ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, ... Patient Advocacy Award in recognition of her extraordinary contributions to the field of ... The Beryl Institute’s annual Patient Experience Conference on March 20 in Denver, ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... partnered with O2X , an active lifestyle company that provides Human Performance ... health of firefighters, police offers, first responders, military officers and others in service ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research ... America Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, ... Segment Forecasts, 2014 - 2025" report to their offering. ... The Latin American ... 21.0 billion by 2025 Low drug registration cost ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
Breaking Medicine Technology: